Compare INDRAPRASTHA MEDICAL with APOLLO HOSPITALS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs APOLLO HOSPITALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL APOLLO HOSPITALS INDRAPRASTHA MEDICAL/
APOLLO HOSPITALS
 
P/E (TTM) x 16.9 83.8 20.2% View Chart
P/BV x 2.7 15.4 17.6% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 INDRAPRASTHA MEDICAL   APOLLO HOSPITALS
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
APOLLO HOSPITALS
Mar-21
INDRAPRASTHA MEDICAL/
APOLLO HOSPITALS
5-Yr Chart
Click to enlarge
High Rs523,284 1.6%   
Low Rs271,070 2.6%   
Sales per share (Unadj.) Rs90.6734.5 12.3%  
Earnings per share (Unadj.) Rs4.89.5 50.3%  
Cash flow per share (Unadj.) Rs8.449.3 16.9%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs29.2319.7 9.1%  
Shares outstanding (eoy) m91.67143.78 63.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.43.0 14.9%   
Avg P/E ratio x8.4230.2 3.6%  
P/CF ratio (eoy) x4.844.1 10.8%  
Price / Book Value ratio x1.46.8 20.1%  
Dividend payout %031.7 0.0%   
Avg Mkt Cap Rs m3,660313,023 1.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,13916,010 13.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,308105,600 7.9%  
Other income Rs m7491 1.4%   
Total revenues Rs m8,315106,091 7.8%   
Gross profit Rs m86411,939 7.2%  
Depreciation Rs m3305,731 5.8%   
Interest Rs m594,492 1.3%   
Profit before tax Rs m4822,207 21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46847 5.4%   
Profit after tax Rs m4361,360 32.1%  
Gross profit margin %10.411.3 92.0%  
Effective tax rate %9.538.4 24.7%   
Net profit margin %5.31.3 407.7%  
BALANCE SHEET DATA
Current assets Rs m1,41536,413 3.9%   
Current liabilities Rs m1,39620,379 6.9%   
Net working cap to sales %0.215.2 1.5%  
Current ratio x1.01.8 56.7%  
Inventory Days Days296 2.2%  
Debtors Days Days3546 75.6%  
Net fixed assets Rs m3,07587,891 3.5%   
Share capital Rs m917719 127.5%   
"Free" reserves Rs m1,76145,243 3.9%   
Net worth Rs m2,67845,962 5.8%   
Long term debt Rs m024,735 0.0%   
Total assets Rs m4,490124,304 3.6%  
Interest coverage x9.11.5 613.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.90.8 217.8%   
Return on assets %11.04.7 234.4%  
Return on equity %16.33.0 550.5%  
Return on capital %20.29.5 213.2%  
Exports to sales %00-   
Imports to sales %00 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA11 0.0%   
Fx inflow Rs m1,408629 223.9%   
Fx outflow Rs m344460 74.8%   
Net fx Rs m1,064169 629.7%   
CASH FLOW
From Operations Rs m86512,734 6.8%  
From Investments Rs m-402-8,723 4.6%  
From Financial Activity Rs m-427-3,401 12.6%  
Net Cashflow Rs m35445 7.9%  

Share Holding

Indian Promoters % 49.4 29.8 165.6%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.0 64.0 0.0%  
FIIs % 0.0 54.5 -  
ADR/GDR % 0.0 0.1 -  
Free float % 49.0 70.1 69.9%  
Shareholders   59,093 67,091 88.1%  
Pledged promoter(s) holding % 0.0 30.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   CHENNAI MEENAKSHI   DR.AGAR.EYE  ASPIRA PATHLAB & DIAGNOSTICS   KIMS  DR. LAL PATHLABS  



Today's Market

Sensex Jumps 400 Points to Hit Fresh Record High; Bajaj Finance & ITC Top Gainers(09:30 am)

Asian stock markets are trading on a steady note today as traders weighed risks from China to the global recovery and the prospect of reduced Federal Reserve stimulus.

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

APOLLO HOSPITALS Announces Quarterly Results (3QFY20); Net Profit Up 9.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, APOLLO HOSPITALS has posted a net profit of Rs 948 m (up 9.0% YoY). Sales on the other hand came in at Rs 25 bn (up 16.6% YoY). Read on for a complete analysis of APOLLO HOSPITALS's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

APOLLO HOSPITALS 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of APOLLO HOSPITALS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of APOLLO HOSPITALS. Also includes updates on the valuation of APOLLO HOSPITALS.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 17, 2021 12:03 PM

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 5-YR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS